Abnormal activity in reward brain circuits in human narcolepsy with cataplexy

Annals of Neurology

Volumn 67, Issue 2, 2010, Pages 190-200

  Ponz, Aurélie ^a,b   Khatami, Ramin ^c   Poryazova, Rositsa ^c   Werth, Esther ^c   Boesiger, Peter ^d,e   Bassetti, Claudio L ^c   Schwartz, Sophie ^a,b  

^a University Medical Center   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYGDALOID NUCLEUS; ARTICLE; CATAPLEXY; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE DURATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MESENCEPHALON; NARCOLEPSY; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; REWARD; VENTRAL TEGMENTUM;

ADULT; ANALYSIS OF VARIANCE; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; EMOTIONS; FEMALE; GAMES, EXPERIMENTAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MOTIVATION; NARCOLEPSY; NEURAL PATHWAYS; OXYGEN; REACTION TIME; REWARD;

EID: 77949406753     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21825     Document Type: Article

References (61)

1. de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998;95:322-327.
2. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573-585.
3. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005;437:1257-1263.
4. Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015.
5. Baumann CR, Bassetti CL. Hypocretins (orexins) and sleep-wake disorders. Lancet Neurol 2005;4:673-682.
6. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-1562.
7. Adamantidis AR, Zhang F, Aravanis AM, et al. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 2007;450:420-424.
8. Bassetti C, Aldrich MS. Narcolepsy. Neurol Clin 1996;14:545-571.
9. Sturzenegger C, Bassetti CL. The clinical spectrum of narcolepsy with cataplexy: a reappraisal. J Sleep Res 2004;13:395-406.
10. Anic-Labat S, Guilleminault C, Kraemer HC, et al. Validation of a cataplexy questionnaire in 983 sleep-disorders patients. Sleep 1999;22:77-87.
11. Schwartz S, Ponz A, Poryazova R, et al. Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy. Brain 2008;131:514-522.
12. Reiss AL, Hoeft F, Tenforde AS, et al. Anomalous hypothalamic responses to humor in cataplexy. PLoS One 2008;3:e2225.
13. Schultz W. Multiple reward signals in the brain. Nat Rev Neurosci 2000;1:199-207.
14. O'Doherty JP, Buchanan TW, Seymour B, Dolan RJ. Predictive neural coding of reward preference involves dissociable responses in human ventral midbrain and ventral striatum. Neuron 2006;49:157-166.
15. Pessiglione M, Seymour B, Flandin G, et al. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 2006;442:1042-1045.
16. Fadel J, Deutch AY. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 2002;111:379-387.
17. Marcus JN, Aschkenasi CJ, Lee CE, et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 2001;435:6-25.
18. Narita M, Nagumo Y, Hashimoto S, et al. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 2006;26:398-405.
19. Korotkova TM, Sergeeva OA, Eriksson KS, et al. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 2003;23:7-11.
20. Harris GC, Wimmer M, Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005;437:556-559.
21. Boutrel B, Kenny PJ, Specio SE, et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 2005;102:19168-19173.
22. Borgland SL, Taha SA, Sarti F, et al. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006;49:589-601.
23. Georgescu D, Zachariou V, Barrot M, et al. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 2003;23:3106-3111.
24. Nishino S, Mignot E. Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol 1997;52:27-78.
25. Guilleminault C, Carskadon M, Dement WC. On the treatment of rapid eye movement narcolepsy. Arch Neurol 1974;30:90-93.
26. Parkes JD, Baraitser M, Marsden CD, Asselman P. Natural history, symptoms and treatment of the narcoleptic syndrome. Acta Neurol Scand 1975;52:337-353.
27. Bassetti C. The spectrum of narcolepsy. In: Bassetti C, Billiard M, Mignot E, eds. Narcolepsy and Hypersomnia. New York, NY: Informa Healthcare; 2007:97-108.
28. Knutson B, Adams CM, Fong GW, Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci 2001;21:RC159.
29. Knutson B, Westdorp A, Kaiser E, Hommer D. FMRI visualization of brain activity during a monetary incentive delay task. Neuroimage 2000;12:20-27.
30. Knutson B, Taylor J, Kaufman M, et al. Distributed neural representation of expected value. J Neurosci 2005;25:4806-4812.
31. Baumann CR, Khatami R, Werth E, Bassetti CL. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy. J Neurol Neurosurg Psychiatry 2006;77:402-404.
32. Penny W, Holmes A, Friston KJ. Random effects analysis. In: Frackowiak RS, Friston KJ, Frith CD, et al, eds. Human Brain Function. 2nd ed. Oxford, UK: Academic Press; 2003:635-654.
33. Friston KJ, Penny WD, Glaser DE. Conjunction revisited. Neuroimage 2005;25:661-667.
34. Friston KJ, Buechel C, Fink GR, et al. Psychophysiological and modulatory interactions in neuroimaging. Neuroimage 1997;6:218-229.
35. Schultz W, Apicella P, Scarnati E, Ljungberg T. Neuronal activity in monkey ventral striatum related to the expectation of reward. J Neurosci 1992;12:4595-4610.
36. Haruno M, Kawato M. Different neural correlates of reward expectation and reward expectation error in the putamen and caudate nucleus during stimulus-action-reward association learning. J Neurophysiol 2006;95:948-959.
37. Vuilleumier P. How brains beware: neural mechanisms of emotional attention. Trends Cogn Sci 2005;9:585-594.
38. Critchley HD, Melmed RN, Featherstone E, et al. Volitional control of autonomic arousal: a functional magnetic resonance study. Neuroimage 2002;16:909-919.
39. D'Ardenne K, McClure SM, Nystrom LE, Cohen JD. BOLD responses reflecting dopaminergic signals in the human ventral tegmental area. Science 2008;319:1264-1267.
40. Knutson B, Cooper JC. Functional magnetic resonance imaging of reward prediction. Curr Opin Neurol 2005;18:411-417.
41. Wager TD, Davidson ML, Hughes BL, et al. Prefrontal-subcortical pathways mediating successful emotion regulation. Neuron 2008;59:1037-1050.
42. Knutson B, Fong GW, Bennett SM, et al. A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI. Neuroimage 2003;18:263-272.
43. Critchley HD, Mathias CJ, Dolan RJ. Neural activity in the human brain relating to uncertainty and arousal during anticipation. Neuron 2001;29:537-545.
44. Vittoz NM, Berridge CW. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 2006;31:384-395.
45. Phelps EA, Delgado MR, Nearing KI, LeDoux JE. Extinction learning in humans: role of the amygdala and vmPFC. Neuron 2004;43:897-905.
46. Boutrel B, de Lecea L. Addiction and arousal: the hypocretin connection. Physiol Behav 2008;93:947-951.
47. Ungless MA, Whistler JL, Malenka RC, Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 2001;411:583-587.
48. Borgland SL, Malenka RC, Bonci A. Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J Neurosci 2004;24:7482-7490.
49. Zheng H, Patterson LM, Berthoud HR. Orexin signaling in the ventral tegmental area is required for high-fat appetite induced by opioid stimulation of the nucleus accumbens. J Neurosci 2007;27:11075-11082.
50. Delgado MR. Reward-related responses in the human striatum. Ann N Y Acad Sci 2007;1104:70-88.
51. Schonberg T, Daw ND, Joel D, O'Doherty JP. Reinforcement learning signals in the human striatum distinguish learners from nonlearners during reward-based decision making. J Neurosci 2007;27:12860-12867.
52. O'Doherty J, Dayan P, Schultz J, et al. Dissociable roles of ventral and dorsal striatum in instrumental conditioning. Science 2004;304:452-454.
53. Chabas D, Habert MO, Maksud P, et al. Functional imaging of cataplexy during status cataplecticus. Sleep 2007;30:153-156.
54. Passouant P, Billard M. The evolution of narcolepsy with age. In: Guilleminault C, Dement WC, Passouant P, eds. Narcolepsy. New York: Spectrum Publications, Inc, 1976:179-196.
55. Tong J, Ross BM, Schmunk GA, et al. Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users. Am J Psychiatry 2003;160:896-903.
56. London ED, Simon SL, Berman SM, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 2004;61:73-84.
57. Ballon JS, Feifel D. A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry 2006;67:554-566.
58. Khatami R, Birkmann S, Bassetti CL. Amygdala dysfunction in narcolepsy-cataplexy. J Sleep Res 2007;16:226-229.
59. Date Y, Ueta Y, Yamashita H, et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A 1999;96:748-753.
60. Critchley HD, Elliott R, Mathias CJ, Dolan RJ. Neural activity relating to generation and representation of galvanic skin conductance responses: a functional magnetic resonance imaging study. J Neurosci 2000;20:3033-3040.
61. Brisbare-Roch C, Dingemanse J, Koberstein R, et al. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 2007;13:150-155.